Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates.
Soluble amyloid-beta (Abeta) aggregates are suspected to play a major role in Alzheimer's disease. Zn2+ at a concentration of a few micromolar, which is too dilute to affect the precipitation equilibrium of Abeta, can destabilize these aggregates [Garai, K., Sengupta, P., Sahoo, B., and Maiti, S. (2006) Biochem. Biophys. Res. Commun. 345, 210-215]. Here we investigate the nature of these aggregates in the context of the precipitation pathway, the mechanism underlying their destabilization, and the biological consequences of this destabilization. We show that the larger soluble aggregates (size >10 nm) form only in supersaturated Abeta solutions, implying that they are intermediates in the pathway toward fibril formation. We also show that Zn2+ destabilizes these intermediates by accelerating their aggregation kinetics. The resulting change in the size distribution of the Abeta solution is sufficient to eliminate its toxicity to cultured mammalian neurons. Our results provide an explanation for the existing observations that Zn2+ at a concentration of a few micromolar significantly reduces Abeta toxicity.
Garai
K
K
Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Colaba, Mumbai 400005, India.
Sahoo
B
B
Kaushalya
S K
SK
Desai
R
R
Maiti
S
S
D016229:Amyloid beta-Peptides / Q000633:toxicity* / Q000648:ultrastructure; D000818:Animals; D011232:Chemical Precipitation; D009474:Neurons / Q000166:cytology / Q000187:drug effects; D020836:Protein Structure, Quaternary; D051381:Rats; D017208:Rats, Wistar; D012995:Solubility / Q000187:drug effects; D015032:Zinc / Q000494:pharmacology*
D016229:Amyloid beta-Peptides; D015032:Zinc